Geriatric screening in the treatment of elderly patients with ovarian carcinoma

Recruiting

• Conditions: Ovarian cancer; ovarian carcinoma; 10038594

• Registration Number: NL-OMON50441
• Lead Sponsor: Antoni van Leeuwenhoek Ziekenhuis

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 11 June 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: Not specified
• Target Recruitment: 320

Inclusion Criteria

- A woman with high suspicion of OR newly diagnosed with ovarian cancer FIGO
stage II, III or IV
- Aged 70 years or older
- Able to complete a Dutch questionnaire
- Written and signed informed consent

Exclusion Criteria

- Not being able to read or write Dutch, as they are not able to complete a
Dutch questionnaire

Study & Design

• Study Type: Observational non invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Primary outcome parameters are the percentage started and completed treatment<br /><br>in *geriatric screening care* and *care as usual* and the difference in<br /><br>percentage in completed treatment (either standard or adapted) between both<br /><br>groups.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Secondary endpoints include health related quality of life; toxicity of<br /><br>treatment; progression free- and overall survival and cost-effectiveness in<br /><br>terms of incremental costs per quality adjusted life year from a societal<br /><br>perspective.</p><br>